Quantcast
Last updated on April 23, 2014 at 11:40 EDT

Latest rheumatoid arthritis Stories

2013-10-28 08:25:51

Budgets are Limiting Wider Prescribing of Biologics; However, Access Will Improve with the Launch of New Drugs and Biosimilars, According to a New Report from Decision Resources BURLINGTON, Mass., Oct. 28, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the rheumatoid arthritis (RA) armamentarium in Argentina and Mexico includes a wide range of premium-priced biologics. However,...

2013-10-28 00:22:31

Hasselt University and INOVA Diagnostics Enter into a Research Collaboration and License Agreement for Novel Diagnostics HASSELT, Belgium and SAN DIEGO, Oct. 28, 2013 /PRNewswire/ -- Hasselt University and INOVA Diagnostics are pleased to announce the completion of an exclusive, worldwide license agreement and research collaboration for technology developed at the University. This technology represents an important advance in the diagnosis of Rheumatoid Arthritis (RA). VIB, the...

2013-10-25 16:23:58

VANCOUVER, Oct. 25, 2013 /PRNewswire/ - Augurex Life Sciences Corp. announced today the expansion of key data related to its innovative 14-3-3eta biomarkers with scheduled presentations next week at the prestigious American College of Rheumatology Annual Meeting, taking place at the San Diego Convention Center, October 25-30, 2013. World-leading investigators will present data, including a late-breaking study, describing 14-3-3eta's clinical utility for rheumatoid arthritis (RA)...

2013-10-25 08:24:30

ATLANTA, Oct. 25, 2013 /PRNewswire/ -- UCB, a global biopharmaceutical company focusing on CNS and immunology treatment and research, is sponsoring multiple data presentations on Cimzia(®) (certolizumab pegol) for the treatment of moderate to severe rheumatoid arthritis and active psoriatic arthritis (PsA) in adults in addition to other oral and poster presentations on investigational data. The data will be presented at the American College of Rheumatology's (ACR) 2013 Annual Scientific...

2013-10-24 12:26:15

EU5 Payers Agree that the Requirement for Direct Comparative Data Is Increasing in the Highly Competitive RA Market, According to a New Report from Decision Resources BURLINGTON, Mass., Oct. 24, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that results from the ADACTA trial, which showed that Roche's RoActemra is superior to AbbVie's Humira as a monotherapy in biologics-naive...

2013-10-23 23:32:32

The process involves a novel physical therapy utilizing stretching, massage and strength training coupled with a neuro anti-inflammatory agent. Reductions in spasticity and recovery of feeling are generally observed on the first day and continue to build with continued treatment according to Neurological Wellness Center physicians. (PRWEB) October 23, 2013 Phillip Koss, owner of http://www.strechforlife.com/ is quick to point out that this process is no panacea. A severely disabled...

2013-10-22 12:28:13

Rheumatoid Patient Foundation to Present Findings at the American College of Rheumatology 2013 Annual Meeting COCOA, Fla., Oct. 22, 2013 /PRNewswire-USNewswire/ -- The Rheumatoid Patient Foundation (RPF) announced today that it will be presenting two abstracts with compelling findings on the nature and assessment of rheumatoid disease at the 2013 American College of Rheumatology (ACR) / Association of Rheumatology Health Professionals (ARHP) Annual Scientific Meeting, to be held...

2013-10-21 12:27:25

Presentations to Highlight Data from Two Recently Completed Clinical Trials for Company's Lead Rheumatoid Arthritis Products CHICAGO, Oct. 21, 2013 /PRNewswire/ -- Medac Pharma, Inc., a privately held pharmaceutical company focused on the development of new molecules and improving the effectiveness of existing medicines, announced today that data from two recently completed clinical trials for its lead product will be presented during the 2013 American College of Rheumatology...

2013-10-21 08:28:45

Society Launches National Conversation on Living With Arthritis www.ThePain.ca; 1-855-599-PAIN; #ThePain TORONTO, Oct. 21, 2013 /CNW/ - The Arthritis Society today launched a nationwide campaign to urge Canadians to speak up and "Share The Pain" they experience in living with arthritis. The Society is aiming to change the conversation about arthritis and trigger a candid, national discussion on the reality of a disease that affects millions of Canadians of every age. "We...

2013-10-18 08:24:23

Approval represents the fourth U.S. indication for Cimzia® ATLANTA, Oct. 18, 2013 /PRNewswire/ -- regulated information - UCB announced today that the U.S. Food and Drug Administration (FDA) has approved Cimzia(®) (certolizumab pegol) for the treatment of adults with active ankylosing spondylitis (AS). The FDA also issued a Complete Response Letter relating to the supplemental Biologics License Application (sBLA) of Cimzia(®) for the treatment of adults with active axial spondyloarthritis...